PCBP2 Reduced Oxidative Stress-Induced Apoptosis in Glioma through cGAS/STING Pathway by METTL3-Mediated m6A

Xiang Chen1, Mingchuan Yu1, Wei Xu2

  • 1Department of Rehabilitation Medicine, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang City, Jiangxi Province, China.

Abstract

Insights

High PCBP2 levels accelerate glioma progression and metastasis by reducing oxidative stress-induced apoptosis via the cGAS/STING pathway. Lower PCBP2 expression correlates with better outcomes in glioma patients.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Glioma is a common and aggressive central nervous system (CNS) tumor with poor prognosis.
  • Oxidative stress is implicated in glioma development and progression.
  • Understanding molecular mechanisms is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the role of PCBP2 in glioma.
  • To elucidate the underlying mechanisms of PCBP2's impact on glioma progression.
  • To explore PCBP2 as a potential therapeutic target.

Main Methods:

  • Quantitative PCR and microarray analysis for gene expression.
  • Western blot and immunofluorescence for protein analysis.
  • Analysis of patient data for overall survival (OS) and disease-free survival (DFS).

Main Results:

  • PCBP2 mRNA and protein levels were significantly upregulated in glioma tissues.
  • High PCBP2 expression was associated with shorter OS and DFS.
  • PCBP2 promoted glioma progression and metastasis, suppressed oxidative stress-induced apoptosis, and inhibited the cGAS/STING pathway.
  • PCBP2 directly interacted with cGAS, and its stability was enhanced by METTL3-mediated m6A modification.

Conclusions:

  • PCBP2 plays a critical role in promoting glioma progression and metastasis.
  • PCBP2 suppresses oxidative stress-induced apoptosis in glioma by inhibiting the cGAS/STING pathway.
  • Targeting PCBP2 may offer a novel strategy to combat glioma and reduce oxidative stress-induced apoptosis.